Literature DB >> 8896571

Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly.

E Belloni1, M Muenke, E Roessler, G Traverso, J Siegel-Bartelt, A Frumkin, H F Mitchell, H Donis-Keller, C Helms, A V Hing, H H Heng, B Koop, D Martindale, J M Rommens, L C Tsui, S W Scherer.   

Abstract

Holoprosencephaly (HPE) is a genetically and phenotypically heterogenous disorder involving the development of forebrain and midface, with an incidence of 1:16,000 live born and 1:250 induced abortions. This disorder is associated with several distinct facies and phenotypic variability: in the most extreme cases, anophthalmia or cyclopia is evident along with a congenital absence of the mature nose. The less severe form features facial dysmorphia characterized by ocular hypertelorism, defects of the upper lip and/or nose, and absence of the olfactory nerves or corpus callosum. Several intermediate phenotypes involving both the brain and face have been described. One of the gene loci, HPE3, maps to the terminal band of chromosome 7. We have performed extensive physical mapping studies and established a critical interval for HPE3, and subsequently identified the sonic hedgehog (SHH) gene as the prime candidate for the disorder. SHH lies within 15-250 kilobases (kb) of chromosomal rearrangements associated with HPE, suggesting that a 'position effect' has an important role in the aetiology of HPE. As detailed in the accompanying report, this role for SHH is confirmed by the detection of point mutations in hereditary HPE patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896571     DOI: 10.1038/ng1196-353

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  169 in total

1.  Vax1, a novel homeobox-containing gene, directs development of the basal forebrain and visual system.

Authors:  M Hallonet; T Hollemann; T Pieler; P Gruss
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

2.  Involvement of the HLXB9 homeobox gene in Currarino syndrome.

Authors:  E Belloni; G Martucciello; D Verderio; E Ponti; M Seri; V Jasonni; M Torre; M Ferrari; L C Tsui; S W Scherer
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 3.  The sonic hedgehog-patched-gli pathway in human development and disease.

Authors:  E H Villavicencio; D O Walterhouse; P M Iannaccone
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

Review 4.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

5.  Signaling by SHH rescues facial defects following blockade in the brain.

Authors:  H Jonathan Chong; Nathan M Young; Diane Hu; Juhee Jeong; Andrew P McMahon; Benedikt Hallgrimsson; Ralph S Marcucio
Journal:  Dev Dyn       Date:  2012-02       Impact factor: 3.780

Review 6.  Mutations in the noncoding genome.

Authors:  Cheryl A Scacheri; Peter C Scacheri
Journal:  Curr Opin Pediatr       Date:  2015-12       Impact factor: 2.856

7.  Reciprocal mouse and human limb phenotypes caused by gain- and loss-of-function mutations affecting Lmbr1.

Authors:  R M Clark; P C Marker; E Roessler; A Dutra; J C Schimenti; M Muenke; D M Kingsley
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

Review 8.  Holoprosencephaly: a paradigm for the complex genetics of brain development.

Authors:  E Roessler; M Muenke
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

9.  Currarino Syndrome and HPE Microform Associated with a 2.7-Mb Deletion in 7q36.3 Excluding SHH Gene.

Authors:  C Coutton; B Poreau; F Devillard; C Durand; S Odent; C Rozel; G Vieville; F Amblard; P-S Jouk; V Satre
Journal:  Mol Syndromol       Date:  2013-10-02

10.  A Single Aspartate Coordinates Two Catalytic Steps in Hedgehog Autoprocessing.

Authors:  Jian Xie; Timothy Owen; Ke Xia; Brian Callahan; Chunyu Wang
Journal:  J Am Chem Soc       Date:  2016-08-19       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.